🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib trial will investigate the effect of N-803 in combination wit...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-02-15
Trial ID
NCT07217496
This is a Phase 3, randomized, blinded, and placebo-controlled clinical tri...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-04-15
Trial ID
NCT07492875
Treatments Being Tested
This early phase I trial tests the safety and how well N-803 works in treat...
Status
Recruiting
Location
Northwestern University
Start Date
2026-04-13
Trial ID
NCT07261657
This study consists of 2 portions. The phase 2 portion is an open-label, si...
Status
Active Not Recruiting
Location
Chan Soon-Shiong Institute for Medicine (CSSIFM)
Start Date
2024-08-07
Trial ID
NCT06061809
Treatments Being Tested
This is a Phase 2, randomized, open-label study evaluating the safety and e...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-06
Trial ID
NCT07578558
Treatments Being Tested
This is a protocol for expanded access use of nogapendekin-alfa inbakicept ...
Status
Available
Location
Chan Soon - Shiong Institute for Medicine
Start Date
TBD
Trial ID
NCT06956547
Treatments Being Tested
This Phase 2 study tests whether adding two immune therapies - nogapendekin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-04-15
Trial ID
NCT07492888
This study will test the safety and tolerability of Anktiva in patients wit...
Status
Recruiting
Location
University of California - San Francisco
Start Date
2025-11-14
Trial ID
NCT07108036
Treatments Being Tested
This study will examine the safety and effectiveness of Anktiva in treating...
Status
Recruiting
Location
Chan Soon-Schiong Institute for Medicine (CSSIFM)
Start Date
2025-09-04
Trial ID
NCT07123727
Treatments Being Tested
This is a single center, phase Ib/II study combining an anti-PD-1 antibody ...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2026-07-07
Trial ID
NCT07355205
Treatments Being Tested